Gene · 2131
Papers1,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial. | Cancers (Basel) | 2021 | 34885165 | PubTator, text mining | PubMed |
| From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity. | Glob Med Genet | 2021 | 34877576 | PubTator, text mining | PubMed |
| Unusual location of osteochondroma in the temporal region in a patient with functional pituitary adenoma. | J Int Med Res | 2021 | 34861124 | PubTator, text mining | PubMed |
| Clinical Characteristics and Mutation Spectrum of Neurofibromatosis Type 1 in 27 Turkish Families. | Balkan Med J | 2021 | 34860164 | PubTator, text mining | PubMed |
| Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression. | Front Oncol | 2021 | 34858858 | PubTator, text mining | PubMed |
| CRISPR Tackles Emerging Viral Pathogens. | Viruses | 2021 | 34834963 | PubTator, text mining | PubMed |
| Inherited Proteoglycan Biosynthesis Defects-Current Laboratory Tools and Bikunin as a Promising Blood Biomarker. | Genes (Basel) | 2021 | 34828260 | PubTator, text mining | PubMed |
| A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker for intra-tumoral myeloid-derived suppressor cells. | iScience | 2021 | 34825135 | PubTator, text mining | PubMed |
| Perturbed body fluid distribution and osmoregulation in response to high salt intake in patients with hereditary multiple exostoses. | Mol Genet Metab Rep | 2021 | 34815940 | PubTator, text mining | PubMed |
| A Comparative Proteomic Analysis of Extracellular Vesicles Associated With Lipotoxicity. | Front Cell Dev Biol | 2021 | 34805145 | PubTator, text mining | PubMed |
| C1 C2 spinal cord compression in hereditary multiple exostoses: case report and review of the literature. | Int J Surg Case Rep | 2021 | 34798549 | PubTator, text mining | PubMed |
| Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review. | Cancers (Basel) | 2021 | 34771640 | PubTator, text mining | PubMed |
| Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71). | Molecules | 2021 | 34770987 | PubTator, text mining | PubMed |
| Surface bone sarcomas: an update on current clinicopathological diagnosis and treatment. | EFORT Open Rev | 2021 | 34760290 | PubTator, text mining | PubMed |
| Modified osteotomy for treatment of forearm deformities (Masada IIb) in hereditary multiple osteochondromas: a retrospective review. | BMC Musculoskelet Disord | 2021 | 34758801 | PubTator, text mining | PubMed |
| CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer. | Aging (Albany NY) | 2021 | 34717291 | PubTator, text mining | PubMed |
| Dysplasia Epiphysealis Hemimelica (Trevor's Disease) in Children, Two New Cases: Diagnosis, Treatment, and Literature Review. | Children (Basel) | 2021 | 34682172 | PubTator, text mining | PubMed |
| Fecal Microbial Transplantation in Critically Ill Patients-Structured Review and Perspectives. | Biomolecules | 2021 | 34680092 | PubTator, text mining | PubMed |
| Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants. | PLoS Pathog | 2021 | 34648606 | PubTator, text mining | PubMed |
| Cellular and Molecular Engineering of Glycan Sialylation in Heterologous Systems. | Molecules | 2021 | 34641494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2131/papers?page=25